As usual, Dr. Miller sheds plenty of light on the ITF's pro-active approach to investigating potential anti-doping violations like the Biogenesis case...
The Biogenesis case in the US is still going on, reportedly with links to tennis. Are you still monitoring the case?That is amazing candor from Dr. Miller, no?
We’re monitoring proceedings in the US.
Are you actively investigating any players as a result of it?
Not going to comment on that.
Did the Biogenesis case take you by surprise?
There have been precedents, Balco, and similar, so the fact that there appears to be a rogue supply of prohibited substances through a type of black market is not without some kind of historical equivalent. So from that point of view, no.
In Part 1 of the interview, Dr. Miller answered questions about off-testing at Grand Slam events:
I understand you now test players on their days off in grand slams. When did that start?I'm pretty sure Dr. Miller didn't actually answer the question...He also answered a question regarding the storing of samples, but his response is so convoluted and unclear that I won't bother posting it.
That’s been permitted under the rules for as long as I can remember. I can’t talk about before my time but it’s been an option for many years.
Has it been stepped up recently?
There is more, around the programme in general, not just in single events, there is more sample collection when players are not competing than there used to be.
Once again the ITF's anti-doping unit has distinguished itself as a beacon of anti-doping prowess. Tennis should be proud.